Logo image of ALHRG.PA

HERIGE (ALHRG.PA) Stock Fundamental Analysis

EPA:ALHRG - Euronext Paris - Matif - FR0000066540 - Common Stock - Currency: EUR

25  +0.6 (+2.46%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALHRG. ALHRG was compared to 16 industry peers in the Trading Companies & Distributors industry. While ALHRG has a great profitability rating, there are some minor concerns on its financial health. ALHRG is valued quite cheap, while showing a decent growth score. This is a good combination! This makes ALHRG very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ALHRG had positive earnings in the past year.
ALHRG had a positive operating cash flow in the past year.
Each year in the past 5 years ALHRG has been profitable.
ALHRG had a positive operating cash flow in each of the past 5 years.
ALHRG.PA Yearly Net Income VS EBIT VS OCF VS FCFALHRG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M 30M

1.2 Ratios

The Return On Assets of ALHRG (6.53%) is better than 93.75% of its industry peers.
ALHRG has a Return On Equity of 14.82%. This is amongst the best in the industry. ALHRG outperforms 81.25% of its industry peers.
Industry RankSector Rank
ROA 6.53%
ROE 14.82%
ROIC N/A
ROA(3y)3.42%
ROA(5y)2.97%
ROE(3y)12.56%
ROE(5y)10.98%
ROIC(3y)N/A
ROIC(5y)N/A
ALHRG.PA Yearly ROA, ROE, ROICALHRG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 15

1.3 Margins

With a decent Profit Margin value of 3.41%, ALHRG is doing good in the industry, outperforming 68.75% of the companies in the same industry.
ALHRG's Profit Margin has improved in the last couple of years.
ALHRG's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 43.42%, ALHRG belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
In the last couple of years the Gross Margin of ALHRG has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 3.41%
GM 43.42%
OM growth 3Y-0.23%
OM growth 5Y12.98%
PM growth 3Y-14.27%
PM growth 5Y37.8%
GM growth 3Y2.69%
GM growth 5Y2.44%
ALHRG.PA Yearly Profit, Operating, Gross MarginsALHRG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

6

2. Health

2.1 Basic Checks

ALHRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALHRG remains at a similar level compared to 1 year ago.
The number of shares outstanding for ALHRG has been reduced compared to 5 years ago.
Compared to 1 year ago, ALHRG has an improved debt to assets ratio.
ALHRG.PA Yearly Shares OutstandingALHRG.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
ALHRG.PA Yearly Total Debt VS Total AssetsALHRG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

ALHRG has an Altman-Z score of 3.15. This indicates that ALHRG is financially healthy and has little risk of bankruptcy at the moment.
ALHRG's Altman-Z score of 3.15 is fine compared to the rest of the industry. ALHRG outperforms 62.50% of its industry peers.
ALHRG has a debt to FCF ratio of 20.35. This is a negative value and a sign of low solvency as ALHRG would need 20.35 years to pay back of all of its debts.
ALHRG has a Debt to FCF ratio of 20.35. This is comparable to the rest of the industry: ALHRG outperforms 56.25% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that ALHRG is somewhat dependend on debt financing.
ALHRG's Debt to Equity ratio of 0.70 is in line compared to the rest of the industry. ALHRG outperforms 43.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 20.35
Altman-Z 3.15
ROIC/WACCN/A
WACC4.66%
ALHRG.PA Yearly LT Debt VS Equity VS FCFALHRG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.39 indicates that ALHRG has no problem at all paying its short term obligations.
ALHRG's Current ratio of 2.39 is amongst the best of the industry. ALHRG outperforms 81.25% of its industry peers.
ALHRG has a Quick Ratio of 1.91. This is a normal value and indicates that ALHRG is financially healthy and should not expect problems in meeting its short term obligations.
ALHRG's Quick ratio of 1.91 is amongst the best of the industry. ALHRG outperforms 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.91
ALHRG.PA Yearly Current Assets VS Current LiabilitesALHRG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.12% over the past year.
Measured over the past years, ALHRG shows a very strong growth in Earnings Per Share. The EPS has been growing by 47.38% on average per year.
Looking at the last year, ALHRG shows a very negative growth in Revenue. The Revenue has decreased by -14.27% in the last year.
The Revenue has been growing slightly by 6.67% on average over the past years.
EPS 1Y (TTM)39.12%
EPS 3Y-4.01%
EPS 5Y47.38%
EPS Q2Q%151.61%
Revenue 1Y (TTM)-14.27%
Revenue growth 3Y11.65%
Revenue growth 5Y6.67%
Sales Q2Q%-26.32%

3.2 Future

The Earnings Per Share is expected to grow by 10.34% on average over the next years. This is quite good.
Based on estimates for the next years, ALHRG will show a very negative growth in Revenue. The Revenue will decrease by -16.91% on average per year.
EPS Next Y2.21%
EPS Next 2Y10.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.21%
Revenue Next 2YN/A
Revenue Next 3Y-16.91%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALHRG.PA Yearly Revenue VS EstimatesALHRG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
ALHRG.PA Yearly EPS VS EstimatesALHRG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 6 8

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 2.96 indicates a rather cheap valuation of ALHRG.
Based on the Price/Earnings ratio, ALHRG is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.47. ALHRG is valued rather cheaply when compared to this.
ALHRG is valuated cheaply with a Price/Forward Earnings ratio of 3.00.
ALHRG's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALHRG is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, ALHRG is valued rather cheaply.
Industry RankSector Rank
PE 2.96
Fwd PE 3
ALHRG.PA Price Earnings VS Forward Price EarningsALHRG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALHRG is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as ALHRG.
Industry RankSector Rank
P/FCF 13.2
EV/EBITDA 2.64
ALHRG.PA Per share dataALHRG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

ALHRG's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ALHRG may justify a higher PE ratio.
PEG (NY)1.34
PEG (5Y)0.06
EPS Next 2Y10.34%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALHRG!.
Industry RankSector Rank
Dividend Yield N/A

HERIGE

EPA:ALHRG (2/4/2025, 7:00:00 PM)

25

+0.6 (+2.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)11-05 2024-11-05
Earnings (Next)N/A N/A
Inst Owners0.86%
Inst Owner ChangeN/A
Ins Owners17.74%
Ins Owner ChangeN/A
Market Cap74.75M
Analysts86.67
Price Target34.68 (38.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.78
Dividend Growth(5Y)29.19%
DP22.12%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 2.96
Fwd PE 3
P/S 0.1
P/FCF 13.2
P/OCF 2.84
P/B 0.45
P/tB 0.64
EV/EBITDA 2.64
EPS(TTM)8.45
EY33.8%
EPS(NY)8.34
Fwd EY33.37%
FCF(TTM)1.89
FCFY7.57%
OCF(TTM)8.81
OCFY35.25%
SpS239.42
BVpS55.05
TBVpS38.8
PEG (NY)1.34
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 6.53%
ROE 14.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.41%
GM 43.42%
FCFM 0.79%
ROA(3y)3.42%
ROA(5y)2.97%
ROE(3y)12.56%
ROE(5y)10.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.95%
ROCE(5y)7.85%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.23%
OM growth 5Y12.98%
PM growth 3Y-14.27%
PM growth 5Y37.8%
GM growth 3Y2.69%
GM growth 5Y2.44%
F-Score8
Asset Turnover1.91
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 20.35
Debt/EBITDA 3.78
Cap/Depr 65.84%
Cap/Sales 2.89%
Interest Coverage N/A
Cash Conversion 86.44%
Profit Quality 23.2%
Current Ratio 2.39
Quick Ratio 1.91
Altman-Z 3.15
F-Score8
WACC4.66%
ROIC/WACCN/A
Cap/Depr(3y)130.39%
Cap/Depr(5y)150%
Cap/Sales(3y)3.56%
Cap/Sales(5y)3.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.12%
EPS 3Y-4.01%
EPS 5Y47.38%
EPS Q2Q%151.61%
EPS Next Y2.21%
EPS Next 2Y10.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.27%
Revenue growth 3Y11.65%
Revenue growth 5Y6.67%
Sales Q2Q%-26.32%
Revenue Next Year3.21%
Revenue Next 2YN/A
Revenue Next 3Y-16.91%
Revenue Next 5YN/A
EBIT growth 1Y-103.11%
EBIT growth 3Y11.4%
EBIT growth 5Y20.51%
EBIT Next Year80%
EBIT Next 3Y8.97%
EBIT Next 5YN/A
FCF growth 1Y128.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y631.63%
OCF growth 3Y-23.55%
OCF growth 5Y5.66%